Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06807515

Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
Thong Chai Institute of Medical Research · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a single-centre, observational prospective study of cancer patients in remission administering FL Nourish capsules (FLNC), a proprietary Chinese Medicine herbal supplement, for the treatment of symptoms associated with qi deficiency and blood stasis syndrome.

Detailed description

Consultation data will be analysed from up to 24 cancer patients in remission receiving routine treatment at Singapore Thong Chai Medical Institution. Each participant will visit the institution in accordance with the protocol which includes up to 9 months of FL Nourish capsule (FLNC) use and up to 8 consultation visits. Participants will be evaluated based on consultation data, questionnaire data, routine blood test data and self-reporting of adverse events or severe adverse events. As this is a non-interventional observational study, all participants would have received FLNC prescriptions according to routine diagnostic and prescribing standards, and there were no additional visits required aside from routine follow up consultations.

Conditions

Timeline

Start date
2025-02-10
Primary completion
2027-02-09
Completion
2027-08-09
First posted
2025-02-04
Last updated
2025-04-09

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06807515. Inclusion in this directory is not an endorsement.

Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission (NCT06807515) · Clinical Trials Directory